Intradigm Announces Allowance of Key RNA Interference Patent
Patent Covers Small Interfering RNA Structural Features Tied to
Inc
Intradigm Corporation (Palo Alto, CA), a leading developer of
targeted, systemic RNA interference (RNAi) therapeutics, announced that
the United States Patent and Trademark Office has allowed U.S. . . .
AutoGenomics Receives a Key European Patent for HPV
Detection.
AutoGenomics (Carlsbad, CA), a leader in providing automated,
molecular testing solutions, has been issued a key European patent for
Human papillomavirus. Patent No.1 499 749 B1, "Human . . .
VNUS Announces Settlement of Patent Litigation with AngioDynamics
and Vascular Solutions.
VNUS Medical Technologies, Inc. (San Jose, CA) has entered into an
agreement with AngioDynamics and Vascular Solutions that settles and
resolves the patent infringement lawsuit between the . . .
University of Miami Confirms Value of Monitoring Cell-Mediated
Immunity Pre- and Post-Transplant.
Manuel R. Carreno, MD, and colleagues in the Departments of Surgery
and Pathology at the University of Miami - Lawrence Miller School of
Medicine (Miami, FL) have corroborated the value of . . .
Senomyx obtains United States patent.(Brief article)
Senomyx, Inc. (San Diego, CA) has patented a method for using
sensory G protein-coupled receptors that recognize chemical sensants,
particularly those involving olfactory and taste receptors; . . .
Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening
Its Targeted Anti-Phospholipid Patent Portfolio - New Claims C
Peregrine Pharmaceuticals, Inc. (Tustin, CA), a clinical stage
biopharmaceutical company developing monoclonal antibodies for the
treatment of cancer and hepatitis C virus infection (HCV), reported . . .
Monogram Biosciences Collaborates with Gilead Sciences for
Elvitegravir Phase III Studies PhenoSense GT and PhenoSense Integrase
Monogram Biosciences, Inc., (S. San Francisco, CA) has signed an
agreement with Gilead Sciences, Inc. to provide resistance testing and
consultative services for Gilead's Elvitegravir Phase III . . .
Immtech Pharmaceuticals and Beijing Capital Medical University
Announce Joint Venture to Provide Contract Research Services in
C
Immtech Pharmaceuticals (New York, NY) and Beijing Capital Medical
University (Beijing, China) one of China's leading academic medical
research centers, signed a Memorandum of Understanding to . . .
DialysisPPO Files Provisional Patent Application for Dialysis
Cost Containment.
DialysisPPO (Phoenixville, PA) has filed a provisional patent
application with the United States Patent and Trademark Office covering
its business method that enables health plans to significantly . . .
Hong Kong University of Science & Technology obtains United
States patent.
Hong Kong University of Science & Technology (Hong Kong) has
patented protein sequences encoding antigenized antibodies for treatment
of foot-and-mouth disease or foot-and-mouth disease virus . . .
Synovics Pharmaceuticals forms a Strategic Joint Venture with
Maneesh Pharmaceuticals.(Company overview)
Synovics Pharmaceuticals, Inc., (Ft. Lauderdale, FL) a specialty
pharmaceutical company, formalized a strategic partnership with Maneesh
Pharmaceuticals, LTD (Mumbai, India) through the formation . . .
Inventure Chemical and Seambiotic Enter Joint Venture to Build
Commercial Algae to Biofuel Plant in Israel Pilot Facility is Cri
Inventure Chemical (Seattle, WA) has entered into a joint venture
with Seambiotic Ltd. (Tel Aviv, Israel) to construct a pilot commercial
biofuel plant in Israel, using algae created from CO2 . . .
Rosetta Genomics Announces Three New Diagnostic Tests to Enter
Development New Development Programs to Include Response Predicti
Rosetta Genomics Ltd. (Rehovot, Israel), a leader in the
development of microRNA-based diagnostics and therapeutics, announced
the advancement of three new diagnostic tests into its . . .
EntreMed's ENMD-2076 Demonstrates Antitumor Activity in
Multiple Myeloma Model.
EntreMed, Inc. (Rockville, MD), a clinical-stage pharmaceutical
company developing therapeutics for the treatment of cancer and
inflammatory diseases, announced the presentation of preclinical . . .
Oncolytics Biotech obtains United States patent.
Oncolytics Biotech, Inc. (Calgary, Canada) has patented methods for
treating proliferative disorders, by administering reovirus to a
Ras-mediated proliferative disorder. The reovirus is . . .
Proteome obtains isobaric mass labelling patent.
Proteome Sciences plc (Cobham, England) announced that the United
States Patent and Trademark Office has issued a Notice of Allowance for
its United States patent application in isobaric mass . . .
Nuevolution Announces Research and Development Collaboration with
Merck.
Nuevolution A/S (Copenhagen, Denmark) entered into a drug discovery
collaboration with Merck & Co., Inc. (Whitehouse Station, NJ)
Nuevolution will apply its proprietary Chemetics drug . . .
Canopus BioPharma Strengthens its CB1400 Platform Technology for
Mucositis and Oncology Treatments Through License Agreement Wit
Canopus BioPharma, Inc. (Los Angeles, CA), a biotechnology company
developing pharmaceutical products and assay methods for patients
suffering from infectious disease, radiation sickness, cancer . . .
Investigational Studies Highlight Potential Utility of Zevalin
Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's
At the 44th Annual Meeting of the American Society of Clinical
Oncology (ASCO), two studies were presented investigating the potential
utility of Zevalin (Ibritumomab Tiuxetan) radioimmunotherapy . . .
Schering-Plough's Sugammadex Provides Fast Reversal of
Effects of Muscle Relaxants.
Schering-Plough (Kennilworth, NJ) announced that sugammadex, a
novel experimental muscle elaxant reversal agent, reversed moderate
(shallow) rocuronium- and vecuronium-induced muscle . . .
|
|